33 completed, 9 terminated, 2 withdrawn, 1 active not recruiting. 45 Phase 1, 20 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 45 | Completed 33, Terminated 9, Withdrawn 2, Active not recruiting 1 |
| Phase 2 | 20 | Completed 17, Terminated 2, Withdrawn 1 |
Follow Adult Gliosarcoma: new trials by email Literature Review of Adult Gliosarcoma trials Research Report on Adult Gliosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients MSC11FCD - Glioblastoma, Adult Gliosarcoma | Phase 1 / Phase 2 | Completed | CHA University | 10 | 2020-06-24 | 2023-01-18 |
| EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma EGFRBi-Armed Autologous T Cells, Laboratory Biomarker Analysis - Adult Brain Glioblastoma, Adult Gliosarcoma | Phase 1 / Phase 2 | Withdrawn | Barbara Ann Karmanos Cancer Institute | 2015-08-01 | 2016-02-15 | |
| Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Dimethyl Fumarate, Temozolomide, Radiation Therapy - Adult Brain Glioblastoma, Adult Giant Cell Glioblastoma | Phase 1 | Completed | Virginia Commonwealth University | 12 | 2015-02-13 | 2019-06-28 |
| Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas Hyperfractionated radiation therapy, Stereotactic radiosurgery, Alisertib - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma | Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 17 | 2015-01-30 | 2025-04-30 |
| Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma radiation therapy, temozolomide, plerixafor - Adult Ependymoblastoma, Adult Giant Cell Glioblastoma | Phase 1 / Phase 2 | Completed | Lawrence Recht | 30 | 2014-11-01 | 2018-10-23 |
| Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas E. coli CD-expressing genetically modified neural stem cells, flucytosine, leucovorin calcium - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1 | Completed | City of Hope Medical Center | 16 | 2014-10-28 | 2026-11-03 |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy 18F-fludeoxyglucose (18F-FDG), 18F-FPPRGD2 - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1 / Phase 2 | Completed | Sanjiv Sam Gambhir | 25 | 2013-03-04 | 2019-10-03 |
| Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme Anti-Endoglin Chimeric Monoclonal Antibody TRC105, Bevacizumab, Laboratory Biomarker Analysis - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 116 | 2012-11-01 | 2018-05-23 |
| High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma Vorinostat, Stereotactic Radiosurgery, Laboratory Biomarker Analysis - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1 | Terminated | National Cancer Institute (NCI) | 30 | 2012-06-01 | 2014-12-23 |
| RO4929097 in Treating Patients With Recurrent Invasive Gliomas gamma-secretase/Notch signalling pathway inhibitor RO4929097, therapeutic conventional surgery, pharmacological study - Adult Anaplastic Oligodendroglioma, Adult Brain Stem Glioma | Phase 1 | Terminated | National Cancer Institute (NCI) | 22 | 2011-07-01 | 2013-02-07 |
| Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases bafetinib, microdialysis, pharmacological study - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma | Phase 1 | Completed | City of Hope Medical Center | 7 | 2010-12-01 | 2018-04-17 |
| RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma gamma-secretase/Notch signalling pathway inhibitor RO4929097, bevacizumab, laboratory biomarker analysis - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 13 | 2010-12-01 | 2015-12-14 |
| A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas flucytosine, polymerase chain reaction, immunohistochemistry staining method - Adult Anaplastic Astrocytoma, Recurrent Grade III Glioma | Phase 1 | Completed | City of Hope Medical Center | 15 | 2010-08-01 | 2017-11-09 |
| Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors aminolevulinic acid, laboratory biomarker analysis, therapeutic conventional surgery - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1 | Terminated | University of Washington | 6 | 2010-06-01 | 2017-02-15 |
| RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma 3-Dimensional Conformal Radiation Therapy, Gamma-Secretase Inhibitor RO4929097, Intensity-Modulated Radiation Therapy - Acoustic Schwannoma, Adult Anaplastic (Malignant) Meningioma | Phase 1 | Completed | National Cancer Institute (NCI) | 22 | 2010-05-01 | 2015-09-29 |
| Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma erlotinib hydrochloride, isotretinoin, laboratory biomarker analysis - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1 | Terminated | Wake Forest University Health Sciences | 5 | 2010-05-01 | 2018-08-01 |
| Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors Gamma-Secretase Inhibitor RO4929097, Cediranib Maleate, Pharmacological Study - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma | Phase 1 | Completed | National Cancer Institute (NCI) | 20 | 2010-05-01 | 2014-12-23 |
| Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma Cediranib Maleate, Cilengitide, Laboratory Biomarker Analysis - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1 | Completed | National Cancer Institute (NCI) | 47 | 2010-03-01 | 2015-04-15 |
| Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma Laboratory Biomarker Analysis, Perifosine, Temsirolimus - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 36 | 2010-01-27 | 2021-07-19 |
| Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme Cilengitide, Clinical Observation, Laboratory Biomarker Analysis - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1 | Terminated | National Cancer Institute (NCI) | 41 | 2009-12-01 | 2015-04-28 |
Showing 20 of 45. Sign in to see all of them.
Gliosarcoma (45) · Glioblastoma (44) · Brain Neoplasms (30) · Astrocytoma (23) · Oligodendroglioma (23) · Glioma (17) · Ependymoma (6) · Neuroectodermal Tumors, Primitive (4) · Breast Neoplasms (3) · Breast Neoplasms, Male (3) · Carcinoma, Non-Small-Cell Lung (3) · Colonic Neoplasms (3) · Glioma, Subependymal (3) · Medulloblastoma (3) · Meningioma (3)
Neoplasms (45) · Neoplasms by Histologic Type (45) · Neoplasms, Glandular and Epithelial (45) · Neoplasms, Nerve Tissue (45) · Neoplasms, Neuroepithelial (45) · Neuroectodermal Tumors (45) · Neoplasms, Germ Cell and Embryonal (44) · Brain Diseases (33) · Central Nervous System Diseases (33) · Neoplasms by Site (33) · Nervous System Diseases (33) · Nervous System Neoplasms (33) · Central Nervous System Neoplasms (32) · Glioma (28) · Astrocytoma (21)
Temozolomide (12) · Radiation (7) · Radiotherapy (7) · Erlotinib Hydrochloride (5) · Radiotherapy, Conformal (5) · Sirolimus (5) · temsirolimus (5) · 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (4) · Cilengitide (3) · Magnetic Resonance Spectroscopy (3) · Radiosurgery (3) · Radiotherapy, Intensity-Modulated (3) · Sorafenib (3) · Vorinostat (3) · cediranib (3)
National Cancer Institute (NCI) (33) · City of Hope Medical Center (4) · Barbara Ann Karmanos Cancer Institute (1) · CHA University (1) · Lawrence Recht (1) · Sanjiv Sam Gambhir (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · University of Washington (1) · Virginia Commonwealth University (1) · Wake Forest University Health Sciences (1)
United States (41) · Canada (2) · South Korea (1)
Jana Portnow (4) · Evanthia Galanis (2) · Timothy Cloughesy (2) · Antonio Omuro (1) · Antonius Miller (1) · Arnab Chakravarti (1) · Daniel Silbergeld (1) · David Brachman (1) · David Peereboom, MD (1) · Edward Pan, MD (1) · Elizabeth Gerstner (1) · Elizabeth R Gerstner, MD (1) · Glenn Lesser (1) · Howard Fine, MD (1) · Jann Sarkaria (1)
PMID 21377994, PMID 22517399, PMID 23380277, PMID 24309981, PMID 24470557, PMID 25113840, PMID 25832688, PMID 25965900, PMID 26062933, PMID 26611425, PMID 30825962, PMID 30850872, PMID 31386061, PMID 33842889, PMID 38197800
U01CA062399 (6), U01CA062475 (6), U01CA137443 (6), U10CA025224 (4), U10CA180821 (3), P30CA008748 (2), U01CA069856 (2), U10CA021661 (2), N01CM00032 (1), P30CA006516 (1), P30CA014599 (1), P30CA016059 (1), P30CA022453 (1), P30CA033572 (1), P30CA056036 (1)